Want to see SGRY full AI Analyst Report?
SGRY Stock Chart & Stats
$14.00
$0.26(1.26%)
At close: 4:00 PM EST
$14.00
$0.26(1.26%)
Day’s Range― - ―
52-Week Range$11.41 - $24.10
Previous CloseN/A
Volume149.01K
Average Volume (3M)1.28M
Market Cap
$2.09B
Enterprise Value$7.17K
Total Cash (Recent Filing)$182.30M
Total Debt (Recent Filing)$4.03B
Price to Earnings (P/E)―
Beta1.17
Next Earnings
Aug 04, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.59
Shares Outstanding130,788,160
10 Day Avg. Volume1,187,197
30 Day Avg. Volume1,283,847
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)1.15
Price to Sales (P/S)0.59
P/FCF Ratio10.05
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$17.42Price Target Upside24.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)0.43
Revenue Forecast (FY)$3.41B
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationStable operating cash flow (~$274M–$300M) and consistently positive free cash flow provide durable internal funding for maintenance capex, selective de novos and interest service. Over 2–6 months this base supports operations and measured reinvestment, albeit modest vs. debt.
MSK/Robotics & Procedure Mix ExpansionMeaningful growth in total joint procedures and adoption of surgical robots shifts case mix toward higher‑acuity, higher‑value procedures. This structural shift supports sustainable revenue per case improvement and margin durability as outpatient orthopedic volumes scale.
Physician Partnerships & De Novo GrowthActive physician recruiting and steady de novo openings reflect the JV/partner model's ability to expand footprint with aligned referral sources. This supports durable volume growth and capital‑efficient expansion, sustaining long‑term site utilization and revenue growth trends.
Bears Say
High & Rising LeverageElevated and increasing leverage materially reduces financial flexibility and raises refinancing and covenant risk if operating performance weakens. High debt burdens limit the company's ability to deploy capital for M&A or buybacks and increases sensitivity to interest rate moves.
Persistent Net LossesDespite positive adjusted EBITDA, recurring GAAP net losses erode retained earnings and depress returns on equity. Persistent bottom‑line losses constrain balance sheet repair, reduce internal capital for strategic initiatives, and limit long‑term allocation flexibility.
Reimbursement & Working Capital PressureProvider tax changes, Medicaid cuts and adverse payer mix create recurring reimbursement headwinds that compress margins. Elevated DSO (~66 days) and working‑capital drag reduce free cash flow conversion, intensifying liquidity stress given the company’s leverage and interest cost profile.
Surgery Partners News
SGRY FAQ
What was Surgery Partners Inc.’s price range in the past 12 months?
Surgery Partners Inc. lowest stock price was $11.41 and its highest was $24.10 in the past 12 months.
What is Surgery Partners Inc.’s market cap?
Surgery Partners Inc.’s market cap is $2.09B.
When is Surgery Partners Inc.’s upcoming earnings report date?
Surgery Partners Inc.’s upcoming earnings report date is Aug 04, 2026 which is in 16 days.
How were Surgery Partners Inc.’s earnings last quarter?
Surgery Partners Inc. released its earnings results on May 05, 2026. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.124 by $0.094.
Is Surgery Partners Inc. overvalued?
According to Wall Street analysts Surgery Partners Inc.’s price is currently Undervalued.
Does Surgery Partners Inc. pay dividends?
Surgery Partners Inc. does not currently pay dividends.
What is Surgery Partners Inc.’s EPS estimate?
Surgery Partners Inc.’s EPS estimate is 0.06.
How many shares outstanding does Surgery Partners Inc. have?
Surgery Partners Inc. has 130,788,160 shares outstanding.
What happened to Surgery Partners Inc.’s price movement after its last earnings report?
Surgery Partners Inc. reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.124. Following the earnings report the stock price went up 0.423%.
Which hedge fund is a major shareholder of Surgery Partners Inc.?
Currently, no hedge funds are holding shares in SGRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Surgery Partners Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.42 (24.40% Upside)
$17.42 (24.40% Upside)
Blogger Sentiment
Bullish
SGRY Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 7.9%
Last 30 Days ▼ 7.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-29.31%
12-Months-Change
Fundamentals
Return on Equity
-4.43%
Trailing 12-Months
Asset Growth
1.17%
Trailing 12-Months
Company Description
Surgery Partners Inc.
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
SGRY Stock 12 Month Forecast
Average Price Target
$17.42
▲(24.40% Upside)
Technical Analysis
HCA Healthcare
―
Encompass Health
―
National Healthcare
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
1.73% Insiders
24.87% Mutual Funds
0.16% Other Institutional Investors
62.09% Public Companies and
Individual Investors